vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and SPS COMMERCE INC (SPSC). Click either name above to swap in a different company.
SPS COMMERCE INC is the larger business by last-quarter revenue ($192.7M vs $168.4M, roughly 1.1× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 12.7%). Over the past eight quarters, SPS COMMERCE INC's revenue compounded faster (13.5% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
SPS Commerce, Inc. is a technology and application software company based in the United States that provides cloud-based supply chain management software. The company's headquarters are located in Minneapolis, Minnesota, but it also has a US office in New Jersey, and international locations in Amsterdam, Beijing, Breukelen, Hong Kong, Kyiv, Melbourne, Montpellier, Sydney, and Toronto.
ESPR vs SPSC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $192.7M |
| Net Profit | — | $25.8M |
| Gross Margin | — | 70.4% |
| Operating Margin | 50.6% | 18.0% |
| Net Margin | — | 13.4% |
| Revenue YoY | 143.7% | 12.7% |
| Net Profit YoY | — | 47.2% |
| EPS (diluted) | $0.32 | $0.69 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $192.7M | ||
| Q3 25 | $87.3M | $189.9M | ||
| Q2 25 | $82.4M | $187.4M | ||
| Q1 25 | $65.0M | $181.5M | ||
| Q4 24 | $69.1M | $170.9M | ||
| Q3 24 | $51.6M | $163.7M | ||
| Q2 24 | $73.8M | $153.6M | ||
| Q1 24 | $137.7M | $149.6M |
| Q4 25 | — | $25.8M | ||
| Q3 25 | $-31.3M | $25.6M | ||
| Q2 25 | $-12.7M | $19.7M | ||
| Q1 25 | $-40.5M | $22.2M | ||
| Q4 24 | — | $17.6M | ||
| Q3 24 | $-29.5M | $23.5M | ||
| Q2 24 | $-61.9M | $18.0M | ||
| Q1 24 | $61.0M | $18.0M |
| Q4 25 | — | 70.4% | ||
| Q3 25 | — | 69.5% | ||
| Q2 25 | — | 68.1% | ||
| Q1 25 | — | 68.7% | ||
| Q4 24 | — | 67.5% | ||
| Q3 24 | — | 68.5% | ||
| Q2 24 | — | 66.1% | ||
| Q1 24 | — | 65.6% |
| Q4 25 | 50.6% | 18.0% | ||
| Q3 25 | -11.4% | 16.4% | ||
| Q2 25 | 8.6% | 14.1% | ||
| Q1 25 | -34.0% | 14.3% | ||
| Q4 24 | -6.4% | 14.5% | ||
| Q3 24 | -31.0% | 15.6% | ||
| Q2 24 | 3.5% | 15.1% | ||
| Q1 24 | 52.5% | 10.3% |
| Q4 25 | — | 13.4% | ||
| Q3 25 | -35.9% | 13.5% | ||
| Q2 25 | -15.4% | 10.5% | ||
| Q1 25 | -62.2% | 12.2% | ||
| Q4 24 | — | 10.3% | ||
| Q3 24 | -57.2% | 14.3% | ||
| Q2 24 | -83.9% | 11.7% | ||
| Q1 24 | 44.3% | 12.0% |
| Q4 25 | $0.32 | $0.69 | ||
| Q3 25 | $-0.16 | $0.67 | ||
| Q2 25 | $-0.06 | $0.52 | ||
| Q1 25 | $-0.21 | $0.58 | ||
| Q4 24 | $-0.14 | $0.46 | ||
| Q3 24 | $-0.15 | $0.62 | ||
| Q2 24 | $-0.33 | $0.48 | ||
| Q1 24 | $0.34 | $0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $151.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $973.9M |
| Total Assets | $465.9M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $151.4M | ||
| Q3 25 | $92.4M | $133.7M | ||
| Q2 25 | $86.1M | $107.6M | ||
| Q1 25 | $114.6M | $94.9M | ||
| Q4 24 | $144.8M | $241.0M | ||
| Q3 24 | $144.7M | $205.8M | ||
| Q2 24 | $189.3M | $271.8M | ||
| Q1 24 | $226.6M | $290.8M |
| Q4 25 | $-302.0M | $973.9M | ||
| Q3 25 | $-451.4M | $958.9M | ||
| Q2 25 | $-433.5M | $949.8M | ||
| Q1 25 | $-426.2M | $920.9M | ||
| Q4 24 | $-388.7M | $854.7M | ||
| Q3 24 | $-370.2M | $829.4M | ||
| Q2 24 | $-344.2M | $703.4M | ||
| Q1 24 | $-294.3M | $683.0M |
| Q4 25 | $465.9M | $1.2B | ||
| Q3 25 | $364.0M | $1.2B | ||
| Q2 25 | $347.1M | $1.1B | ||
| Q1 25 | $324.0M | $1.1B | ||
| Q4 24 | $343.8M | $1.0B | ||
| Q3 24 | $314.1M | $1.0B | ||
| Q2 24 | $352.3M | $854.5M | ||
| Q1 24 | $373.1M | $839.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $45.9M |
| Free Cash FlowOCF − Capex | — | $38.2M |
| FCF MarginFCF / Revenue | — | 19.8% |
| Capex IntensityCapex / Revenue | 0.0% | 4.0% |
| Cash ConversionOCF / Net Profit | — | 1.78× |
| TTM Free Cash FlowTrailing 4 quarters | — | $152.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $45.9M | ||
| Q3 25 | $-4.3M | $60.6M | ||
| Q2 25 | $-31.4M | $32.3M | ||
| Q1 25 | $-22.6M | $40.0M | ||
| Q4 24 | $-35.0M | $40.6M | ||
| Q3 24 | $-35.3M | $53.3M | ||
| Q2 24 | $-7.2M | $29.4M | ||
| Q1 24 | $53.8M | $34.1M |
| Q4 25 | — | $38.2M | ||
| Q3 25 | — | $54.6M | ||
| Q2 25 | — | $25.7M | ||
| Q1 25 | — | $33.8M | ||
| Q4 24 | — | $34.3M | ||
| Q3 24 | $-35.5M | $48.1M | ||
| Q2 24 | $-7.3M | $24.4M | ||
| Q1 24 | $53.8M | $30.5M |
| Q4 25 | — | 19.8% | ||
| Q3 25 | — | 28.7% | ||
| Q2 25 | — | 13.7% | ||
| Q1 25 | — | 18.6% | ||
| Q4 24 | — | 20.1% | ||
| Q3 24 | -68.7% | 29.4% | ||
| Q2 24 | -9.9% | 15.9% | ||
| Q1 24 | 39.0% | 20.4% |
| Q4 25 | 0.0% | 4.0% | ||
| Q3 25 | 0.0% | 3.2% | ||
| Q2 25 | 0.0% | 3.6% | ||
| Q1 25 | 0.0% | 3.4% | ||
| Q4 24 | 0.0% | 3.6% | ||
| Q3 24 | 0.3% | 3.2% | ||
| Q2 24 | 0.1% | 3.3% | ||
| Q1 24 | 0.1% | 2.4% |
| Q4 25 | — | 1.78× | ||
| Q3 25 | — | 2.37× | ||
| Q2 25 | — | 1.64× | ||
| Q1 25 | — | 1.80× | ||
| Q4 24 | — | 2.31× | ||
| Q3 24 | — | 2.27× | ||
| Q2 24 | — | 1.63× | ||
| Q1 24 | 0.88× | 1.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
SPSC
| Recurring Revenues | $184.5M | 96% |
| One Time Revenues | $8.1M | 4% |
| Set Up Fees | $4.1M | 2% |
